BioLeap is a molecule design company that leverages its proprietary technology platform to identify and optimize lead compounds where other approaches have not been successful.
Collaboration
BioLeap creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents, and generates fast-follower compounds for early market entry. Learn more about how our technology can help solve your molecule discovery problems.
News/Events
January 9, 2012
Kyorin and BioLeap enter into Research Collaboration | Read More
December 12, 2011
Southern Research Institute Enters Research Collaboration with BioLeap | Read More
November 30, 2011
January 9 – 12: BioLeap will Attend JP Morgan Healthcare Conference, San Francisco, CA | Read More